A novel PCR-free hybridization method for titering gene therapy vectors in crude cell lysates and various in-process matrices

Maintaining the accuracy and efficiency of AAV genome titer quantification is crucial in gene therapy manufacturing. This interactive poster explores a novel PCR-free assay that enhances speed, reliability, and flexibility. By utilizing DNA hybridization, immunochemistry, and bio-layer interferometry (BLI), this assay simplifies titer quantification and improves workflow efficiency. NEW INTERACTIVE FORMAT Listen to our expert speaker. Watch the video. Read the summary. Focus in on the data. Download the PDF. It has never been easier to quickly access the information you want. All in one place—at the click of a button.

Please enter your email to access content Read now